OKYO Pharma Ltd (OKYO) Form 6-K — Sep 8, 2026
OKYO Pharma announced it will participate in the Cantor Global Healthcare Conference held September 9-11, 2026, with a fireside chat on Thursday, September 10 at 8:35 AM ET. The chat will feature Chief Medical Officer Flavio Mantelli and Chief Development Officer Gary Jacob, moderated by Cantor Fitzgerald's Eric Fitzgerald, and the company will also take one-on-one meetings. The company framed its conference presence around recent positive feedback from an FDA Type D meeting, which it said validated the regulatory and clinical path forward for urcosimod, as well as a strengthened cash position reflected in its recently filed annual report.
Key figures
- Phase3 timing
- second half of 2026
- Conference dates
- September 9-11, 2026
- Fireside chat time
- Thursday, September 10 at 8:35 AM ET
- Phase3 planned enrollment
- approximately 111 patients
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.